| Neuromyelitis optica spectrum disorders S Huda, D Whittam, M Bhojak, J Chamberlain, C Noonan, A Jacob, ... Clinical Medicine 19 (2), 169-176, 2019 | 291 | 2019 |
| Clinical features and diagnostic usefulness of antibodies to clustered acetylcholine receptors in the diagnosis of seronegative myasthenia gravis PMR Cruz, M Al-Hajjar, S Huda, L Jacobson, M Woodhall, S Jayawant, ... JAMA neurology 72 (6), 642-649, 2015 | 151 | 2015 |
| Treatment of MOG-IgG-associated disorder with rituximab: an international study of 121 patients DH Whittam, A Cobo-Calvo, AS Lopez-Chiriboga, S Pardo, M Gornall, ... Multiple sclerosis and related disorders 44, 102251, 2020 | 149 | 2020 |
| IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients I Koneczny, JAA Stevens, A De Rosa, S Huda, MG Huijbers, A Saxena, ... Journal of autoimmunity 77, 104-115, 2017 | 120 | 2017 |
| Treatment of MOG antibody associated disorders: results of an international survey DH Whittam, V Karthikeayan, E Gibbons, R Kneen, S Chandratre, ... Journal of neurology 267, 3565-3577, 2020 | 107 | 2020 |
| Rituximab in neurological disease: principles, evidence and practice DH Whittam, EC Tallantyre, S Jolles, S Huda, RJ Moots, HJ Kim, ... Practical Neurology 19 (1), 5-20, 2019 | 96 | 2019 |
| Long‐term safety and efficacy of Eculizumab in Aquaporin‐4 IgG‐positive NMOSD DM Wingerchuk, K Fujihara, J Palace, A Berthele, M Levy, HJ Kim, ... Annals of neurology 89 (6), 1088-1098, 2021 | 86 | 2021 |
| Ocular myasthenia gravis: controversies and updates SH Wong, S Huda, A Vincent, GT Plant Current neurology and neuroscience reports 14, 1-10, 2014 | 78 | 2014 |
| Factors associated with relapse and treatment of myelin oligodendrocyte glycoprotein antibody–associated disease in the United Kingdom C Satukijchai, R Mariano, S Messina, M Sa, MR Woodhall, NP Robertson, ... JAMA network open 5 (1), e2142780-e2142780, 2022 | 74 | 2022 |
| Association of maintenance intravenous immunoglobulin with prevention of relapse in adult myelin oligodendrocyte glycoprotein antibody–associated disease JJ Chen, S Huda, Y Hacohen, M Levy, I Lotan, A Wilf-Yarkoni, ... JAMA neurology 79 (5), 518-525, 2022 | 68 | 2022 |
| Serological and experimental studies in different forms of myasthenia gravis A Vincent, S Huda, M Cao, H Cetin, I Koneczny, P Rodriguez‐Cruz, ... Annals of the New York Academy of Sciences 1413 (1), 143-153, 2018 | 67 | 2018 |
| IgG-specific cell-based assay detects potentially pathogenic MuSK-Abs in seronegative MG S Huda, P Waters, M Woodhall, MI Leite, L Jacobson, A De Rosa, ... Neurology: Neuroimmunology & Neuroinflammation 4 (4), e357, 2017 | 66 | 2017 |
| Use of cell-based assays in myasthenia gravis and other antibody-mediated diseases PMR Cruz, S Huda, P López-Ruiz, A Vincent Experimental neurology 270, 66-71, 2015 | 64 | 2015 |
| Retinal optical coherence tomography in neuromyelitis optica FC Oertel, S Specovius, HG Zimmermann, C Chien, S Motamedi, ... Neurology: Neuroimmunology & Neuroinflammation 8 (6), e1068, 2021 | 59 | 2021 |
| An 11-year retrospective experience of antibodies against the voltage-gated potassium channel (VGKC) complex from a tertiary neurological centre S Huda, SH Wong, P Pettingill, D O’Connell, A Vincent, M Steiger Journal of Neurology 262, 418-424, 2015 | 50 | 2015 |
| Predictors of relapse in MOG antibody associated disease: a cohort study S Huda, D Whittam, R Jackson, V Karthikeayan, P Kelly, S Linaker, ... BMJ open 11 (11), e055392, 2021 | 49 | 2021 |
| Rituximab abrogates aquaporin-4–specific germinal center activity in patients with neuromyelitis optica spectrum disorders V Damato, J Theorell, A Al-Diwani, AK Kienzler, M Makuch, B Sun, ... Proceedings of the National Academy of Sciences 119 (24), e2121804119, 2022 | 39 | 2022 |
| Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis B Singh, S Lant, S Cividini, JWS Cattrall, LC Goodwin, L Benjamin, ... PLoS One 17 (6), e0263595, 2022 | 39 | 2022 |
| Characteristics Of acetylcholine‐receptor‐antibody–negative myasthenia gravis in a South African cohort S Huda, MR Woodhall, A Vincent, JM Heckmann Muscle & nerve 54 (6), 1023-1029, 2016 | 38 | 2016 |
| Longitudinal retinal changes in MOGAD FC Oertel, ES Sotirchos, HG Zimmermann, S Motamedi, S Specovius, ... Annals of Neurology 92 (3), 476-485, 2022 | 36 | 2022 |
